Back

ALDAS score for low-voltage area burden identifies differential benefit of low-voltage-guided ablation in persistent atrial fibrillation: insights from the SUPPRESS-AF trial

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atrial substrate and atrial fibrillation outcomes Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Akihiro Sunaga

Osaka University Graduate School of Medicine, Suita (Japan)

6 More presentations in this session

Presentation thumbnail
BMI-dependent sex differences in atrial tachyarrhythmia recurrence despite greater low-voltage substrate in women: a SUPPRESS-AF subgroup analysis
Doctor N. Tanaka (Osaka, JP)
Abstract Slides
Presentation thumbnail
Impact of substrate modification and shift in recurrence pattern in elderly patients with persistent atrial fibrillation: a sub-analysis of the SUPPRESS-AF trial
Doctor T. Kanda (Osaka, JP)
Abstract Slides
Presentation thumbnail
Right atrial structural remodeling outweighs frequency-defined drivers in persistent atrial fibrillation: the multicenter randomized PAD-AF trial
Doctor K. Matsuda (Sendai, JP)
Abstract Slides
Presentation thumbnail
Atrial substrate burden determines mitral regurgitation improvement after low-voltage area ablation: a post-hoc analysis of the SUPPRESS-AF randomized trial
Doctor A. Sugino (Osaka, JP)
Abstract Slides
Presentation thumbnail
Impact of the right atrial substrate on arrhythmia recurrence following atrial fibrillation ablation
Doctor N. Bodagh (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Atrial substrate and atrial fibrillation outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Identifying suitable candidates for left atrial low-voltage area ablation in persistent atrial fibrillation: a post-hoc analysis of the SUPPRESS-AF trial
1 September 2025
thumbnail
Congress Presentation
Feasibility of atrial fibrillation burden quantification and its impact on quality-of-life after ablation procedure using continuous monitoring with a smartwatch
22 November 2025
thumbnail
Congress Presentation
Assessing ASD arrhythmogenic substrate using atrial strain echocardiography: a prognostic tool?
13 December 2025
thumbnail
Congress Presentation
Clinical risk scores and left atrial low voltage areas in atrial fibrillation
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources